Filter posts by category

Radiotheranostics

Radiotheranostics is an advanced approach in modern oncology that combines diagnostic imaging and targeted radionuclide therapy within a unified strategy. It uses radiolabelled compounds that bind selectively to tumour-associated targets, allowing clinicians to first visualise disease distribution and then deliver therapeutic radiation to the same molecular sites. This integrated model supports personalised treatment planning by confirming adequate tumour uptake before therapy. Radiotheranostics has shown particular promise in prostate and neuroendocrine cancers, improving precision while limiting exposure to healthy tissue. Linking diagnosis directly with treatment enables real-time assessment of response and adaptive care. Ongoing advances in molecular targeting continue to expand its role in precision cancer medicine.

home » radiotheranostics

Scroll to Top